国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2010年
12期
1467-1469
,共3页
低分子肝素钙%参脉注射液%慢性肺源性心脏病
低分子肝素鈣%參脈註射液%慢性肺源性心髒病
저분자간소개%삼맥주사액%만성폐원성심장병
Low molecular weight heparins calcium%Shenmai injection%Chronic pulmonary heart disease
目的 观察低分子肝索钙联合参麦注射液治疗慢性肺源性心脏病的效果.方法 选取50例慢性肺源性心脏病患者,并随机分为观察组和对照组,每组25例,每组均给予持续低流量吸氧、控制感染、祛痰平喘、强心利尿等常规治疗,观察组在常规治疗基础上加用低分子肝素钙联合参脉注射液治疗.结果 观察组显效19例,有效6例,无效0例,总有效率100%;对照组显效11例,有效9例,无效5例,总有效率80%,两组总有效率比较差异有极显著性(P<0.01).结论 应用低分子肝索钙联合参脉注射液治疗,能有效地改善临床症状,提高动脉血氧分压,降低动脉血二氧化碳分压,是治疗慢性肺源性心脏病的有效方法.
目的 觀察低分子肝索鈣聯閤參麥註射液治療慢性肺源性心髒病的效果.方法 選取50例慢性肺源性心髒病患者,併隨機分為觀察組和對照組,每組25例,每組均給予持續低流量吸氧、控製感染、祛痰平喘、彊心利尿等常規治療,觀察組在常規治療基礎上加用低分子肝素鈣聯閤參脈註射液治療.結果 觀察組顯效19例,有效6例,無效0例,總有效率100%;對照組顯效11例,有效9例,無效5例,總有效率80%,兩組總有效率比較差異有極顯著性(P<0.01).結論 應用低分子肝索鈣聯閤參脈註射液治療,能有效地改善臨床癥狀,提高動脈血氧分壓,降低動脈血二氧化碳分壓,是治療慢性肺源性心髒病的有效方法.
목적 관찰저분자간색개연합삼맥주사액치료만성폐원성심장병적효과.방법 선취50례만성폐원성심장병환자,병수궤분위관찰조화대조조,매조25례,매조균급여지속저류량흡양、공제감염、거담평천、강심이뇨등상규치료,관찰조재상규치료기출상가용저분자간소개연합삼맥주사액치료.결과 관찰조현효19례,유효6례,무효0례,총유효솔100%;대조조현효11례,유효9례,무효5례,총유효솔80%,량조총유효솔비교차이유겁현저성(P<0.01).결론 응용저분자간색개연합삼맥주사액치료,능유효지개선림상증상,제고동맥혈양분압,강저동맥혈이양화탄분압,시치료만성폐원성심장병적유효방법.
Objective To explore the efficacy of low molecular weight heparins calcium combined with Shengmai injection in the treatment of chronic cor pulmonale. Methods 50 patients with chronic cor pulmonale were randomly assigned to receive conventional therapy including administration of continuous low-flow oxygen, antibiotics, expectorants, bronchodilators, digitalis glycosides, and diuretics (control group, 25 patients), or the same conventional therapy plus low molecular weight heparins calcium and Shangmai injection (study group, 25 patients). Results There was signigicant difference in the total effective rate between the study group and the control group in the (100% vs. 80%, P<0.05). ConclusionsLow molecular weight heparins calcium combined with Shengmai injection is effective in improving clinical symptoms, and increasing PaCO2 while reducing PaCO2, thus is an effective therapy for chronic pulmonary heart disease.
